WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'7101 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 18'5851 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 1'273  1'269  1'264  1'258  1'253  1'185  1'056  966 
Births 14  14  14  14  15  20  22  22 
Surviving infants 14  14  14  14  15  20  22  22 
Pop. less than 5 years 71  72  73  74  77  99  98  109 
Pop. less than 15 years 246  252  257  262  267  305  306  344 
Female 15-49 years 331  331  331  332  333  337  295  255 

Number of reported cases

(Click for retrospective incidence data for Mauritius)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  35 
Mumps
ChartChart
  13  14  11 
Pertussis
ChartChart
  12 
Polio*
ChartChart
 
Rubella
ChartChart
  10 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mauritius)
Vaccine year result method % card seen                                                
BCG 1984  98  EPI   94  98  97  99  99  99  88  87  89 
DTP1 1984  93  EPI   94  98  97  99  99  99  88 
DTP3 1984  89  EPI   94  97  97  98  98  98  88  85  89 
DTP4          91  90 
IPV1         
HepB_BD          88 
HepB3          97  97  98  98  98  88 
Hib3          97  97  98  98  98 
JapEnc         
MCV1          99  98  99  99  99  84  76 
MCV2          96  85  85  90  89 
PCV1         
PCV3         
Pol3 1984  89  EPI   94  98  98  98  98  98  88  86  90 
Rota1          74 
RotaC          66 
Rubella1          99  98  99  99  99 
TT2plus          83  85  85  95  95  76  58 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mauritius)
BCG
ChartChart
  98  97  99  99  99  88  87  89 
DTP1
ChartChart
  98  97  99  99  99  88  95  96 
DTP3
ChartChart
  97  97  98  98  98  88  85  89 
HepB3
ChartChart
  97  97  98  98  98  88 
HepB_BD
ChartChart
 
Hib3
ChartChart
  97  97  98  98  98 
IPV1
ChartChart
 
MCV1
ChartChart
  99  98  99  99  99  84  76 
MCV2
ChartChart
  85  85  85  90  89 
PAB
ChartChart
  95  95  95  95  95  79  61 
PCV3
ChartChart
 
Pol3
ChartChart
  98  98  98  98  98  88  86  90 
RCV1
ChartChart
  99  98  99  99  99  84 
RotaC
ChartChart
  66 

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 30
From 80 to 89% 70
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 month; Yes
DT 18 months; 5 years; Yes
DTaPHib 6, 10, 14 weeks; 18 months; Yes
HepB 6, 10, 14 weeks; Yes workers at risk, dialysis patients, travelers
IPV 6, 10, 14 weeks; 18 months; Yes
Influenza 6-23 months; >= 60 years; Yes chronic illness, pregnant women, health care workers, Haj and other travellers and airport staff
MMR 12 months; 5 years; Yes
MenACWY Yes Travelers
OPV 6, 10, 14 weeks; 18 months; Yes
Rotavirus 6, 10 weeks; Yes
TT Yes pregnant women, injured persons
Typhoid Yes Travelers
YF Yes Travelers

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number   10  10  10  10 

System performance

Total Nº districts in country number 10  10  10  10  10  10  10 
Nº districts with DTP3 coverage >=80% number 10  10  10  10  10  10  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 20  30  30  30 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100      100  100     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No  No   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.